Preoperative visual decrease possible after phacoemulsification surgery

Article

Though rare, visual decreases can occur within 1 day postoperatively after phacoemulsification surgery.

Visual decreases are rare after phacoemulsification, but they can occur within 1 day postoperatively,1 according to professors Harry Rosen and Stephen Vernon from, respectively, the Charing Cross Hospital, Imperial College Healthcare National Health Service Trust, London, and the Ophthalmic Service, The Park Hospital, Nottingham, UK.

The safety and efficacy of phacoemulsification have increased to the point that it is no longer standard practice to examine patients the day after surgery, they pointed out. However, because of the rarity of visual decreases, the investigators stated, “Clinicians are therefore likely to be unfamiliar with the potential causes of reduced vision when presented with a patient in the immediate postoperative period.”

In light of this, Rosen and Vernon conducted a literature review to pinpoint the cause of visual decreases early postoperatively. They found various optical, anterior segment, lens-related and posterior segment causes, such as a shallow anterior chamber, lens dislocation, refractive surprise of 1 diopter or more, corneal abrasion, corneal edema, corneal endothelial decompensation, toxic anterior segment syndrome, hyphema, endophthalmitis, opacification, vitreous hemorrhage, and macular holes, among other.

However, paracentral acute middle maculopathy (PAMM), according to the authors, is unique in that it lacks positive findings during clinical examinations, and should be considered as a diagnosis of exclusion.

The investigators described that postoperatively, PAMM is characterized by a dense central scotoma presenting on the first postoperative day, often with no clinical signs on the examination.

“The diagnosis is defined by a hyperreflective band on optical coherence tomography confined to the retinal inner nuclear layer (INL), with subsequent thinning and loss of the negative signal layer of the INL,” they said.

PAMM is believed to result from transient ischemia of the deep and intermediate retinal capillary plexus, causing irreversible INL necrosis.

“Clinicians are becoming increasingly unfamiliar with the causes of visual loss 1 day following cataract surgery," Rosen and Vernon concluded. "We reviewed the differential causes and their presentations as an aid to clinicians reviewing such patients in emergency care. PAMM is a unique condition in its paucity of positive clinical examination findings, and should be considered as a diagnosis of exclusion, with the appropriate radiological evidence.”

Reference
1. Rosen H, Vernon S. Unexpected poor vision within 24 h of uneventful phacoemulsification surgery—a review. J Clin Med. 2023;12: 48; https://doi.org/10.3390/jcm12010048

Recent Videos
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
© 2025 MJH Life Sciences

All rights reserved.